The highest proportion of patients who reported hypoglycemia were using insulin (n = 152, 41.75%), followed by those receiving sulfonylureas (n = 98, 26.92%), metformin (n = 69, 18.95%), and combination treatment (n = 45, 12.36%). This evidence concerns the gene INS and Hypoglycemia.